Companies in #Vaccines
Found 5 companies operating in this sector.
Aurobindo Pharma Limited (NSE: AUROPHARMA; BSE: 524804) is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, New Jersey. Aurobindo develops, manufactures, and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs) across oral solids, injectables, and over-the-counter products, with manufacturing operations in India, the U.S., Brazil, and Portugal. The company is one of the largest generic-ARV (antiretroviral) suppliers globally and is expanding into biosimilars, vaccines, and peptides through its biologics division.
BioNTech is a public biotechnology company developing mRNA-based medicines, cancer immunotherapies, infectious-disease vaccines, and antibody-based oncology programs.
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company with a portfolio spanning immunology, central nervous system disorders, diabetes, and vaccines. It is the originator of Radicava (edaravone) for ALS and has been divesting non-core plants as part of a post-buyout strategic pivot.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered in New York City. The company develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
Sanofi (NASDAQ: SNY; Euronext: SAN) is a global biopharmaceutical company with major franchises in immunology (Dupixent, partnered with Regeneron), vaccines (Beyfortus, Fluzone, Dengvaxia), rare disease (Genzyme-legacy Pompe, Fabry, MS), and a growing oncology pipeline. Sanofi has been reshaping its R&D portfolio toward immunology and rare disease while spinning off its consumer health unit.